Symbols / DNTH Stock $87.39 -2.71% Dianthus Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
DNTH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Marino Garcia M.B.A.
Exch · Country NCM · United States
Market Cap 4.76B
Enterprise Value 3.48B
Income -162.34M
Sales 2.04M
FCF (ttm) -75.45M
Book/sh 11.41
Cash/sh 9.09
Employees 92
Insider 10d —
IPO Jun 21, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -17.09
PEG —
P/S 2,337.07
P/B 7.66
P/C —
EV/EBITDA -19.59
EV/Sales 1,710.91
Quick Ratio 13.16
Current Ratio 13.32
Debt/Eq 0.28
LT Debt/Eq —
EPS (ttm) -4.20
EPS next Y -5.11
EPS Growth —
Revenue Growth -78.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-03-09
ROA -24.58%
ROE -38.38%
ROIC —
Gross Margin 100.00%
Oper. Margin -244.86%
Profit Margin 0.00%
Shs Outstand 54.45M
Shs Float 41.98M
Insider Own 0.13%
Instit Own 95.81%
Short Float 13.89%
Short Ratio 6.26
Short Interest 6.56M
52W High 96.50
vs 52W High -9.44%
52W Low 16.64
vs 52W Low 425.18%
Beta 0.21
Impl. Vol. 63.87%
Rel Volume 0.32
Avg Volume 1.01M
Volume 321.40K
Target (mean) $125.46
Tgt Median $123.00
Tgt Low $98.00
Tgt High $200.00
# Analysts 13
Recom Strong_buy
Prev Close $89.82
Price $87.39
Change -2.71%
About

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$125.46
Mean price target
2. Current target
$87.39
Latest analyst target
3. DCF / Fair value
$-24.94
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$87.39
Low
$98.00
High
$200.00
Mean
$125.46

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 init Wolfe Research — → Outperform $98
2026-03-19 init Wells Fargo — → Overweight $135
2026-03-12 main Wedbush Outperform → Outperform $103
2026-03-10 main Wedbush Outperform → Outperform $80
2026-03-10 up Raymond James Outperform → Strong Buy $123
2026-03-10 main Baird Outperform → Outperform $132
2026-03-10 main Clear Street Buy → Buy $130
2026-03-09 main HC Wainwright & Co. Buy → Buy $130
2026-03-09 main Oppenheimer Outperform → Outperform $145
2026-03-09 main Truist Securities Buy → Buy $110
2026-03-04 main Guggenheim Buy → Buy $200
2026-02-11 main Wedbush Outperform → Outperform $55
2026-02-02 main Jefferies Buy → Buy $81
2026-01-08 main Truist Securities Buy → Buy $63
2025-12-22 reit Wedbush Outperform → Outperform $46
2025-11-10 main HC Wainwright & Co. Buy → Buy $47
2025-11-06 main Wedbush Outperform → Outperform $46
2025-10-14 init Truist Securities — → Buy $56
2025-09-17 init Clear Street — → Buy $100
2025-09-12 main Stifel Buy → Buy $65
News
RSS: Latest DNTH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-09 SAVITZ RYAN Chief Financial Officer — 8,224 $89.84 $738,844
2026-04-09 SAVITZ RYAN Chief Financial Officer — 8,224 $17.88 $147,045
2026-03-31 SOTEROPOULOS PAULA Director — 599 $80.11 $47,986
2026-03-31 SOTEROPOULOS PAULA Director — 599 $8.44 $5,056
2026-03-31 SAVITZ RYAN Chief Financial Officer — 114,367 $78.33 $9,492,596
2026-03-31 SAVITZ RYAN Chief Financial Officer — 114,367 $8.44 $1,342,857
2026-03-24 SOTEROPOULOS PAULA Director — 27,594 $78.05 $2,153,712
2026-03-24 SOTEROPOULOS PAULA Director — 27,594 $8.44 $232,893
2026-03-16 GARCIA MARINO Chief Executive Officer — 65,292 $6.70 $499,975
2026-03-12 CARR EDWARD Officer — 43,682 $80.71 $3,559,495
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2.04
-67.35%
6.24
+120.63%
2.83
-55.96%
6.42
Operating Revenue
2.04
-67.35%
6.24
+120.63%
2.83
-55.96%
6.42
Operating Expense
179.97
+66.49%
108.10
+111.96%
51.00
+41.19%
36.12
Research And Development
145.64
+75.25%
83.11
+153.05%
32.84
+11.78%
29.38
Selling General And Administration
34.33
+37.36%
24.99
+37.64%
18.16
+169.30%
6.74
General And Administrative Expense
34.33
+37.36%
24.99
+37.64%
18.16
+169.30%
6.74
Other Gand A
34.33
+37.36%
24.99
+37.64%
18.16
+169.30%
6.74
Total Expenses
179.97
+66.49%
108.10
+111.96%
51.00
+41.19%
36.12
Operating Income
-177.93
-74.68%
-101.86
-111.45%
-48.17
-62.17%
-29.70
Total Operating Income As Reported
-177.93
-74.68%
-101.86
-111.45%
-48.17
-62.17%
-29.70
EBITDA
-177.50
-74.96%
-101.45
-112.16%
-47.82
-61.78%
-29.56
Normalized EBITDA
-177.96
-75.26%
-101.54
-112.71%
-47.73
-60.75%
-29.69
Reconciled Depreciation
0.43
+3.88%
0.41
+16.06%
0.35
+141.50%
0.15
EBIT
-177.93
-74.68%
-101.86
-111.45%
-48.17
-62.17%
-29.70
Total Unusual Items
0.45
+436.90%
0.08
+198.82%
-0.09
-162.50%
0.14
Total Unusual Items Excluding Goodwill
0.45
+436.90%
0.08
+198.82%
-0.09
-162.50%
0.14
Net Income
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Pretax Income
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Net Non Operating Interest Income Expense
16.12
-7.18%
17.36
+264.50%
4.76
+316.07%
1.15
Net Interest Income
16.12
-7.18%
17.36
+264.50%
4.76
+316.07%
1.15
Interest Income Non Operating
16.12
-7.18%
17.36
+264.50%
4.76
+316.07%
1.15
Interest Income
16.12
-7.18%
17.36
+264.50%
4.76
+316.07%
1.15
Other Income Expense
-0.52
-11.28%
-0.47
-224.14%
-0.14
-272.62%
0.08
Other Non Operating Income Expenses
-0.97
-75.81%
-0.55
-823.33%
-0.06
-15.38%
-0.05
Gain On Sale Of Security
0.45
+436.90%
0.08
+198.82%
-0.09
-162.50%
0.14
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Net Income From Continuing Operation Net Minority Interest
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Net Income From Continuing And Discontinued Operation
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Net Income Continuous Operations
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Normalized Income
-162.79
-91.40%
-85.05
-95.66%
-43.47
-51.93%
-28.61
Net Income Common Stockholders
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Diluted EPS
—
-2.55
+69.82%
-8.45
-339.70%
-1.92
Basic EPS
—
-2.55
+69.82%
-8.45
-339.70%
-1.92
Basic Average Shares
—
33.31
+546.41%
5.15
-65.22%
14.82
Diluted Average Shares
—
33.31
+546.41%
5.15
-65.22%
14.82
Diluted NI Availto Com Stockholders
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
530.92
+41.95%
374.01
+108.47%
179.41
+115.86%
83.11
Current Assets
409.44
+45.76%
280.90
+58.30%
177.45
+116.32%
82.03
Cash Cash Equivalents And Short Term Investments
404.30
+46.89%
275.24
+58.44%
173.72
+130.12%
75.49
Cash And Cash Equivalents
51.09
+124.14%
22.79
-82.78%
132.32
+761.21%
15.37
Other Short Term Investments
353.21
+39.91%
252.45
+509.88%
41.39
-31.16%
60.12
Receivables
0.05
-93.56%
0.81
+68.83%
0.48
-91.52%
5.64
Accounts Receivable
0.05
0.00
—
—
Other Receivables
—
—
0.18
-80.38%
0.94
Prepaid Assets
5.00
+11.20%
4.50
+63.61%
2.75
+222.89%
0.85
Other Current Assets
0.09
-75.77%
0.35
-29.56%
0.50
+850.94%
0.05
Total Non Current Assets
121.48
+30.48%
93.10
+4664.79%
1.95
+81.43%
1.08
Net PPE
1.63
-6.53%
1.75
+118.38%
0.80
-16.32%
0.96
Gross PPE
1.94
-0.15%
1.94
+116.28%
0.90
-9.03%
0.99
Accumulated Depreciation
-0.30
-57.51%
-0.19
-98.97%
-0.10
-223.33%
-0.03
Machinery Furniture Equipment
0.60
+55.04%
0.39
+37.23%
0.28
+63.95%
0.17
Construction In Progress
—
—
—
0.00
Other Properties
1.34
-13.91%
1.55
+152.52%
0.61
-24.45%
0.81
Investments And Advances
110.14
+34.76%
81.73
0.00
—
Other Non Current Assets
9.72
+0.90%
9.63
+734.40%
1.15
+853.72%
0.12
Total Liabilities Net Minority Interest
37.52
+74.27%
21.53
+104.38%
10.54
+11.43%
9.45
Current Liabilities
30.73
+66.55%
18.45
+91.59%
9.63
+17.09%
8.22
Payables And Accrued Expenses
19.66
+57.29%
12.50
+233.04%
3.75
-34.05%
5.69
Payables
9.72
+112.38%
4.58
+75.44%
2.61
+123.65%
1.17
Accounts Payable
9.72
+112.38%
4.58
+75.44%
2.61
+123.65%
1.17
Current Accrued Expenses
9.94
+25.44%
7.92
+592.91%
1.14
-74.73%
4.52
Pensionand Other Post Retirement Benefit Plans Current
9.52
+84.65%
5.15
-3.86%
5.36
+157.25%
2.08
Current Debt And Capital Lease Obligation
0.37
+14.69%
0.32
-23.26%
0.42
+19.14%
0.35
Current Capital Lease Obligation
0.37
+14.69%
0.32
-23.26%
0.42
+19.14%
0.35
Current Deferred Liabilities
1.19
+148.02%
0.48
+379.00%
0.10
+0.00%
0.10
Current Deferred Revenue
1.19
+148.02%
0.48
+379.00%
0.10
+0.00%
0.10
Total Non Current Liabilities Net Minority Interest
6.79
+120.49%
3.08
+240.60%
0.90
-26.44%
1.23
Long Term Debt And Capital Lease Obligation
1.02
-12.98%
1.17
+597.02%
0.17
-61.64%
0.44
Long Term Capital Lease Obligation
1.02
-12.98%
1.17
+597.02%
0.17
-61.64%
0.44
Non Current Deferred Liabilities
5.77
+202.41%
1.91
+159.24%
0.74
-6.95%
0.79
Non Current Deferred Revenue
5.77
+202.41%
1.91
+159.24%
0.74
-6.95%
0.79
Preferred Securities Outside Stock Equity
—
—
—
21.35
Stockholders Equity
493.40
+39.98%
352.48
+108.73%
168.87
+129.27%
73.66
Common Stock Equity
493.40
+39.98%
352.48
+108.73%
168.87
+480.61%
-44.37
Capital Stock
0.04
+38.71%
0.03
+106.67%
0.01
-99.99%
118.02
Common Stock
0.04
+38.71%
0.03
+106.67%
0.01
0.00
Preferred Stock
0.00
0.00
0.00
-100.00%
118.02
Share Issued
43.22
+38.91%
31.12
+109.99%
14.82
0.00%
14.82
Ordinary Shares Number
43.22
+38.91%
31.12
+109.99%
14.82
0.00%
14.82
Additional Paid In Capital
829.60
+57.50%
526.73
+103.98%
258.23
+15446.72%
1.66
Retained Earnings
-336.73
-93.09%
-174.39
-95.02%
-89.42
-94.96%
-45.87
Gains Losses Not Affecting Retained Earnings
0.49
+361.32%
0.11
+125.53%
0.05
+129.19%
-0.16
Other Equity Adjustments
0.49
+361.32%
0.11
+125.53%
0.05
+129.19%
-0.16
Total Equity Gross Minority Interest
493.40
+39.98%
352.48
+108.73%
168.87
+129.27%
73.66
Total Capitalization
493.40
+39.98%
352.48
+108.73%
168.87
+129.27%
73.66
Working Capital
378.71
+44.30%
262.45
+56.39%
167.82
+127.37%
73.81
Invested Capital
493.40
+39.98%
352.48
+108.73%
168.87
+480.61%
-44.37
Total Debt
1.39
-7.04%
1.49
+154.87%
0.58
-25.76%
0.79
Capital Lease Obligations
1.39
-7.04%
1.49
+154.87%
0.58
-25.76%
0.79
Net Tangible Assets
493.40
+39.98%
352.48
+108.73%
168.87
+129.27%
73.66
Tangible Book Value
493.40
+39.98%
352.48
+108.73%
168.87
+480.61%
-44.37
Available For Sale Securities
110.14
+34.76%
81.73
—
—
Duefrom Related Parties Current
0.00
-100.00%
0.81
+174.49%
0.29
-93.74%
4.70
Investmentin Financial Assets
110.14
+34.76%
81.73
—
—
Preferred Stock Equity
—
—
—
118.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-129.06
-65.08%
-78.18
-112.09%
-36.86
-26.80%
-29.07
Cash Flow From Continuing Operating Activities
-129.06
-65.08%
-78.18
-112.09%
-36.86
-26.80%
-29.07
Net Income From Continuing Operations
-162.34
-91.05%
-84.97
-95.08%
-43.55
-52.95%
-28.48
Depreciation Amortization Depletion
0.43
+3.88%
0.41
+16.06%
0.35
+141.50%
0.15
Depreciation
0.43
+3.88%
0.41
+16.06%
0.35
+141.50%
0.15
Depreciation And Amortization
0.43
+3.88%
0.41
+16.06%
0.35
+141.50%
0.15
Other Non Cash Items
—
-0.15
—
—
Stock Based Compensation
22.79
+76.77%
12.89
+344.62%
2.90
+91.04%
1.52
Operating Gains Losses
-0.51
-242.57%
-0.15
—
—
Gain Loss On Investment Securities
-0.51
-242.57%
-0.15
—
—
Change In Working Capital
16.73
+4865.24%
-0.35
-107.22%
4.86
+394.13%
-1.65
Change In Receivables
0.76
+329.48%
-0.33
-106.38%
5.16
+223.98%
-4.16
Changes In Account Receivables
-0.05
0.00
—
—
Change In Prepaid Assets
-0.23
+85.32%
-1.60
-1401.63%
0.12
+119.49%
-0.63
Change In Payables And Accrued Expense
11.28
+37.68%
8.19
+1139.18%
0.66
-71.01%
2.28
Change In Payable
11.28
+37.68%
8.19
+1139.18%
0.66
-71.01%
2.28
Change In Account Payable
11.28
+37.68%
8.19
+1139.18%
0.66
-71.01%
2.28
Change In Other Working Capital
4.57
+194.71%
1.55
+2920.00%
-0.06
-106.17%
0.89
Change In Other Current Assets
0.36
+104.39%
-8.16
-694.84%
-1.03
-3212.90%
-0.03
Investing Cash Flow
-122.83
+57.17%
-286.81
-1516.15%
20.25
+133.86%
-59.82
Cash Flow From Continuing Investing Activities
-122.83
+57.17%
-286.81
-1516.15%
20.25
+133.86%
-59.82
Capital Expenditure
-0.21
-102.86%
-0.10
+4.55%
-0.11
+20.86%
-0.14
Capital Expenditure Reported
-0.21
-102.86%
-0.10
+4.55%
-0.11
+20.86%
-0.14
Net Investment Purchase And Sale
-122.62
+57.23%
-286.71
-1507.98%
20.36
+134.12%
-59.68
Purchase Of Investment
-435.01
-5.15%
-413.71
-620.47%
-57.42
+6.90%
-61.68
Sale Of Investment
312.39
+145.98%
127.00
+63.27%
77.78
+3789.25%
2.00
Financing Cash Flow
280.12
+9.59%
255.62
+91.37%
133.57
+38.17%
96.68
Cash Flow From Continuing Financing Activities
280.12
+9.59%
255.62
+91.37%
133.57
+38.17%
96.68
Net Issuance Payments Of Debt
—
0.00
0.00
0.00
Issuance Of Debt
—
0.00
-100.00%
0.38
0.00
Repayment Of Debt
—
0.00
+100.00%
-0.38
0.00
Long Term Debt Issuance
—
0.00
-100.00%
0.38
0.00
Long Term Debt Payments
—
0.00
+100.00%
-0.38
0.00
Net Long Term Debt Issuance
—
0.00
0.00
0.00
Net Common Stock Issuance
272.27
+1.14%
269.20
+273.89%
72.00
0.00
Proceeds From Stock Option Exercised
8.22
+654.22%
1.09
+21700.00%
0.01
0.00
Net Other Financing Charges
-0.36
+97.52%
-14.66
-123.82%
61.57
+1952.26%
-3.32
Changes In Cash
28.23
+125.81%
-109.37
-193.50%
116.97
+1402.07%
7.79
Beginning Cash Position
23.02
-82.61%
132.39
+758.29%
15.43
+101.95%
7.64
End Cash Position
51.25
+122.63%
23.02
-82.61%
132.39
+758.29%
15.43
Free Cash Flow
-129.27
-65.13%
-78.28
-111.75%
-36.97
-26.57%
-29.21
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Amortization Of Securities
-6.16
-2.41%
-6.02
-322.91%
-1.42
-134.82%
-0.61
Common Stock Issuance
272.27
+1.14%
269.20
+273.89%
72.00
0.00
Issuance Of Capital Stock
272.27
+1.14%
269.20
+273.89%
72.00
-28.00%
100.00
Net Preferred Stock Issuance
—
—
0.00
-100.00%
100.00
Preferred Stock Issuance
—
—
0.00
-100.00%
100.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category